|
시장보고서
상품코드
2056162
체외진단 위탁생산 시장(2026-2030년)Global In Vitro Diagnostics Contract Manufacturing Market 2026-2030 |
||||||
세계의 체외진단 위탁생산 시장은 2025년부터 2030년까지 145억 8,640만 달러 증가하고, 예측 기간 동안 CAGR은 13.3%에 달할 것으로 예측됩니다.
본 보고서에서는 전 세계 체외진단 위탁생산 시장에 대해 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론, 약 25개 업체를 대상으로 한 업체 분석을 제공합니다.
본 보고서에서는 현재의 시장 상황, 최신 시장 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 전 세계적으로 만성 질환 및 감염증 유병률의 증가, 진단 검사 건수의 증가, 원스톱형 IVD 위탁생산에 대한 수요 확대, 그리고 운영 비용 최적화라는 전략적 요구에 힘입어 성장하고 있습니다.
본 조사는 업계 주요 관계자들의 의견을 포함한 1차 정보와 2차 정보를 객관적으로 종합하여 실시되었습니다. 본 보고서에는 주요 기업 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 세분 시장, 그리고 공급업체 현황이 수록되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년 대비 | 11.8% |
| CAGR | 13.3% |
| 증가액 | 145억 8,640만 달러 |
본 조사에서는 생산 워크플로우에 대한 고도화된 자동화, 로봇 공학 및 디지털 트윈 기술의 광범위한 도입이 향후 몇 년간 전 세계 체외진단 위탁생산 시장의 성장을 견인할 주요 요인 중 하나라고 분석하고 있습니다. 또한, IVD 장비의 리스 및 현장 진단(POCT)과 분산형 분자진단 방식의 확산과 통합을 통해 시장에서 상당한 수요가 발생할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 디바이스별
제9장 시장 세분화 : 서비스 유형별
제10장 시장 세분화 : 기술별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSMThe global in vitro diagnostics contract manufacturing market is forecasted to grow by USD 14586.4 mn during 2025-2030, accelerating at a CAGR of 13.3% during the forecast period. The report on the global in vitro diagnostics contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of chronic and infectious diseases and growing volume of diagnostic testing, increasing demand for one-stop-shop ivd contract manufacturing, strategic imperative for operational cost optimization.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 11.8% |
| CAGR | 13.3% |
| Incremental Value | $14586.4 mn |
Technavio's global in vitro diagnostics contract manufacturing market is segmented as below:
By Device
- IVD consumables
- IVD equipment or instrument
By Service Type
- Assay development
- Manufacturing
- Others
By Technology
- Immunoassays
- Molecular diagnostics
- Clinical chemistry
- Hematology
- Microbiology
Geography
- Asia
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Switzerland
- Spain
- Italy
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the broad adoption of advanced automation, robotics, and digital twin technology in production workflows as one of the prime reasons driving the global in vitro diagnostics contract manufacturing market growth during the next few years. Also, leasing of ivd equipment and acceleration and integration of point-of-care and decentralized molecular testing formats will lead to sizable demand in the market.
The report on the global in vitro diagnostics contract manufacturing market covers the following areas:
- Global in vitro diagnostics contract manufacturing market sizing
- Global in vitro diagnostics contract manufacturing market forecast
- Global in vitro diagnostics contract manufacturing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global in vitro diagnostics contract manufacturing market vendors that include Benchmark Electronics Inc., Celestica Inc., Cenogenics Corp., Flex Ltd., Forefront Medical Technology, Fujirebio Holdings Inc., Gerresheimer AG, HIARC Inc., Invetech, Jabil Inc., Kimball Electronics Inc., Merck KGaA, Nolato AB, Nova Biomedical Corp., Phillips Medisize, Plexus Corp., Sanmina Corp., Sartorius AG, Tecomet Inc., Thermo Fisher Scientific Inc.. Also, the global in vitro diagnostics contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Device
- Executive Summary - Chart on Market Segmentation by Service Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global In Vitro Diagnostics Contract Manufacturing Market 2020 - 2024
- Historic Market Size - Data Table on Global In Vitro Diagnostics Contract Manufacturing Market 2020 - 2024 ($ million)
- 5.2 Device segment analysis 2020 - 2024
- Historic Market Size - Device Segment 2020 - 2024 ($ million)
- 5.3 Service Type segment analysis 2020 - 2024
- Historic Market Size - Service Type Segment 2020 - 2024 ($ million)
- 5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global in vitro diagnostics contract manufacturing market
- 6.2 Impact of geopolitical conflicts on global in vitro diagnostics contract manufacturing market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Device
- 8.1 Market segments
- 8.2 Comparison by Device
- 8.3 IVD consumables - Market size and forecast 2025-2030
- 8.4 IVD equipment or instrument - Market size and forecast 2025-2030
- 8.5 Market opportunity by Device
- Market opportunity by Device ($ million)
9 Market Segmentation by Service Type
- 9.1 Market segments
- 9.2 Comparison by Service Type
- 9.3 Assay development - Market size and forecast 2025-2030
- 9.4 Manufacturing - Market size and forecast 2025-2030
- 9.5 Others - Market size and forecast 2025-2030
- 9.6 Market opportunity by Service Type
- Market opportunity by Service Type ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- 10.2 Comparison by Technology
- 10.3 Immunoassays - Market size and forecast 2025-2030
- 10.4 Molecular diagnostics - Market size and forecast 2025-2030
- 10.5 Clinical chemistry - Market size and forecast 2025-2030
- 10.6 Hematology - Market size and forecast 2025-2030
- 10.7 Microbiology - Market size and forecast 2025-2030
- 10.8 Market opportunity by Technology
- Market opportunity by Technology ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 Asia - Market size and forecast 2025-2030
- 12.3.1 China - Market size and forecast 2025-2030
- 12.3.2 India - Market size and forecast 2025-2030
- 12.3.3 Japan - Market size and forecast 2025-2030
- 12.3.4 South Korea - Market size and forecast 2025-2030
- 12.3.5 Thailand - Market size and forecast 2025-2030
- 12.3.6 Indonesia - Market size and forecast 2025-2030
- 12.4 North America - Market size and forecast 2025-2030
- 12.4.1 US - Market size and forecast 2025-2030
- 12.4.2 Canada - Market size and forecast 2025-2030
- 12.4.3 Mexico - Market size and forecast 2025-2030
- 12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 UK - Market size and forecast 2025-2030
- 12.5.3 France - Market size and forecast 2025-2030
- 12.5.4 Switzerland - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 Italy - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 Argentina - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Australia - Market size and forecast 2025-2030
- 12.6.7 Israel - Market size and forecast 2025-2030
- 12.6.8 Turkey - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global prevalence of chronic and infectious diseases and growing volume of diagnostic testing
- Increasing demand for one-stop-shop IVD contract manufacturing
- Strategic imperative for operational cost optimization
- 13.2 Market challenges
- Stringent regulatory disharmony and complex burden of continuous international compliance auditing
- Escalating intellectual property protection risks and information security vulnerabilities in shared collaborative workflows
- Volatile global supply chains and raw material deficits at certain regions
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Broad adoption of advanced automation, robotics, and digital twin technology in production workflows
- Leasing of IVD equipment
- Acceleration and integration of point-of-care and decentralized molecular testing formats
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Benchmark Electronics Inc.
- Benchmark Electronics Inc. - Overview
- Benchmark Electronics Inc. - Business segments
- Benchmark Electronics Inc. - Key offerings
- Benchmark Electronics Inc. - Segment focus
- SWOT
- 15.5 Celestica Inc.
- Celestica Inc. - Overview
- Celestica Inc. - Business segments
- Celestica Inc. - Key offerings
- Celestica Inc. - Segment focus
- SWOT
- 15.6 Cenogenics Corp.
- Cenogenics Corp. - Overview
- Cenogenics Corp. - Product / Service
- Cenogenics Corp. - Key offerings
- SWOT
- 15.7 Flex Ltd.
- Flex Ltd. - Overview
- Flex Ltd. - Business segments
- Flex Ltd. - Key offerings
- Flex Ltd. - Segment focus
- SWOT
- 15.8 Forefront Medical Technology
- Forefront Medical Technology - Overview
- Forefront Medical Technology - Product / Service
- Forefront Medical Technology - Key offerings
- SWOT
- 15.9 Fujirebio Holdings Inc.
- Fujirebio Holdings Inc. - Overview
- Fujirebio Holdings Inc. - Product / Service
- Fujirebio Holdings Inc. - Key offerings
- SWOT
- 15.10 Gerresheimer AG
- Gerresheimer AG - Overview
- Gerresheimer AG - Business segments
- Gerresheimer AG - Key offerings
- Gerresheimer AG - Segment focus
- SWOT
- 15.11 Jabil Inc.
- Jabil Inc. - Overview
- Jabil Inc. - Business segments
- Jabil Inc. - Key offerings
- Jabil Inc. - Segment focus
- SWOT
- 15.12 Kimball Electronics Inc.
- Kimball Electronics Inc. - Overview
- Kimball Electronics Inc. - Product / Service
- Kimball Electronics Inc. - Key offerings
- SWOT
- 15.13 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.14 Nolato AB
- Nolato AB - Overview
- Nolato AB - Business segments
- Nolato AB - Key offerings
- Nolato AB - Segment focus
- SWOT
- 15.15 Plexus Corp.
- Plexus Corp. - Overview
- Plexus Corp. - Business segments
- Plexus Corp. - Key offerings
- Plexus Corp. - Segment focus
- SWOT
- 15.16 Sanmina Corp.
- Sanmina Corp. - Overview
- Sanmina Corp. - Product / Service
- Sanmina Corp. - Key offerings
- SWOT
- 15.17 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
